On our blog, you can find content curated by the VIB community. Discover our research through the eyes of our scientists.Want to be kept up-to-date on our biotechnological news and stories? Join our community and subscribe to our bi-monthly newsletter here.

VIB Blog

On our blog, you can find content curated by the VIB community. Discover our research through the eyes of our scientists.Want to be kept...

Get to know the researchers driving cutting-edge research at VIB and delve into the latest advancements in life sciences.

VIB Blog: Insights and innovations in life sciences research

Op onze blog vindt u inhoud samengesteld door de VIB-gemeenschap. Ontdek ons onderzoek door de ogen van onze wetenschappers.

Dutch

Dutch (Belgium)

English

English (Global)

#475569

Discover scywalker, VIB's groundbreaking workflow for long-read single-cell transcriptome sequencing. Uncover new isoforms, streamline massive datasets, and explore diverse applications from neuroscience to plant biology.

Revolutionizing single-cell analysis with scywalker

Scywalker: Enabling long-read single-cell transcriptome sequencing and analysis 

“There is more to be discovered, if you develop the right tools” 

Long-read single-cell sequencing combines the best of two worlds: the detailed, full-length transcript information from long-reads and the granular, cell-specific resolution of single-cell approaches. Making sense of the data though, is easier said than done. Existing nanopore single-cell data analysis tools simply cannot handle the massive data sets now emerging from long-read sequencing.

Discover the latest insights from VIB's Tech Watch team on groundbreaking life science technologies shaping the future. Explore trends like synthetic biology and dynamic single-cell readouts that are set to revolutionize research in 2025.

Emerging Life Science Technologies: Trends for 2025

The VIB Tech Watch team on Trends in Technology for 2025

“We’ll see a shift from exploring what exists, to creating what’s possible”

As we’re counting down to the new year, it’s time to reflect, take stock, and make plans. Which new and emerging tools are bound to take the research world by storm in the next year? What new developments are here to stay, and which ones will rapidly be taken over?

Relive the best stories of the past year with our editor's pick

VIB's top stories of 2024: the year in review

From groundbreaking scientific discoveries to remarkable moments of innovation, join us in celebrating 2024 at VIB through our editor's pick of the Top 10 Stories.

VIB and J&J team up to harness bacterial enzymes for peptide synthesis

"Bacteria are brilliant chemists" 

Peptides make powerful drugs, but they are difficult to synthesize. The pharmaceutical company Johnson & Johnson teams up with VIB experts to explore how to harness the biosynthetic creativity of microbes to make peptide mass manufacturing more cost-effective and sustainable.

The field of synthetic biology has seen remarkable developments in the last decade or two

(Re)building life: The past, present, and future of synthetic biology 

If we understand living systems as wholes constructed from parts, can we design new parts or redesign existing ones to build living systems and components according to desired specifications?

Exploring metabolomics with Sandrien Desmet of the VIB Metabolomics Core Ghent 

Deciphering metabolism with Sandrien Desmet

Every second, countless chemical reactions power the processes that keep us alive. From breaking down food for energy to detoxifying harmful substances, our cells are constantly producing and using tiny molecules called metabolites. These metabolites are the byproducts of metabolism – the chemical engine that drives all living organisms.

A collaborative fellowship program offering cutting-edge career development for scientists in research infrastructure

Advancing career pathways in research infrastructure with ARISE2

VIB is excited to announce its participation in ARISE2, the European career accelerator designed to foster the growth and expertise of scientists working within research infrastructures. This MSCA-funded postdoctoral fellowship program, launched by EMBL, aims to cultivate the next generation of technophile infrastructure scientists through an intensive three-year fellowship. ARISE2 not only provides specialized training in advanced technology development but also supports interdisciplinary collaboration, professional skills building, and tailored career support.

Henne joins the VIB-KU Leuven Center for Brain & Disease Research as new PI

Meet Henne Holstege

Henne Holstege has spent her career exploring the genetics of neurodegenerative diseases and healthy aging. Her groundbreaking research on cognitively healthy centenarians has been instrumental in understanding how certain individuals defy age-related cognitive decline, potentially paving the way to new, protective approaches against Alzheimer’s and other age-related diseases. As of November 1st, Holstege joins the VIB-KU Leuven Center for Brain & Disease Research in Leuven to dive deeper into the molecular mechanisms that underlie aging.

Meet Jan Remsik, a new group leader at the VIB-KU Leuven Center for Cancer Biology. As he embarks on this exciting chapter of his career, his PhD student Alia Fazal Salom took the opportunity to ask him a few questions.

Meet group leader Jan Remsik, who studies brain metastasis

Thank you. I come from Bratislava but spent quite some time in New York City, from where I moved to Belgium. And one of the things I am looking forward the most to enjoying here is, obviously, the Belgian chocolate!

BE.Amycon is an initiative uniting scientists, doctors, and patients in Belgium to combat amyloidosis. Learn about the project’s goals, key players, and the importance of collaboration for advancing diagnosis and treatment on World Amyloidosis Day.

BE.Amycon: A United Front Against Amyloidosis in Belgium

For World Amyloidosis Day on 26 October, we introduce BE.Amycon, a new VIB Grand Challenges initiative uniting scientists, doctors, and patients...

BE.Amycon: A united front against Amyloidosis in Belgium

For World Amyloidosis Day on 26 October, we introduce BE.Amycon, a new VIB Grand Challenges initiative uniting scientists, doctors, and patients across Belgium to address the challenges posed by amyloidosis. We interview Rodrigo Gallardo, BE.Amycon Project Lead, and other core members of the network to find out more.